{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:00Z","timestamp":1790677380923,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ymgme.2012.07.014","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T19:19:56Z","timestamp":1342811996000},"page":"111-115","source":"Crossref","is-referenced-by-count":11,"title":["Physiotherapy management in late-onset Pompe disease: Clinical practice in 88 patients"],"prefix":"10.1016","volume":"107","author":[{"given":"Marein M.","family":"Favejee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bionka M.A.","family":"Huisstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B.J.","family":"Bussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Kruijshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.07.014_bb0005","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.07.014_bb0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.07.014_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"van Capelle","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0030","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease N","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0035","first-page":"319","article-title":"Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise","volume":"63","author":"Fowler","year":"1982","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0040","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.apmr.2007.07.024","article-title":"Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review","volume":"88","author":"Cup","year":"2007","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2012.07.014_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","article-title":"Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy","volume":"35","author":"Slonim","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.07.014_bb0055","first-page":"185","article-title":"The effects of exercise on a patient with severe acid maltase deficiency","volume":"6","author":"Leutholtz","year":"1996","journal-title":"Eur. J. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.ymgme.2012.07.014_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ymgme.2011.05.013","article-title":"Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy","volume":"104","author":"Terzis","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.07.014_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mus.880060306","article-title":"Respiratory improvement by muscle training in adult-onset acid maltase deficiency","volume":"6","author":"Martin","year":"1983","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2012.07.014_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ymgme.2011.05.006","article-title":"Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease","volume":"104","author":"Jones","year":"2011","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T01:26:48Z","timestamp":1542850008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212002703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":14,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1096719212002703"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.07.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}